Review article: Potential cellular therapies for renal disease: Can we translate results from animal studies to the human condition?

Nephrology

Volumn 14, Issue 6, 2009, Pages 544-553

  Little, Melissa H ^a   Rae, Fiona K ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

CELL DIFFERENTIATION; CHRONIC KIDNEY DISEASE; EMBRYONIC STEM CELL; EXPERIMENTAL ANIMAL; GENETIC MODEL; GLOMERULONEPHRITIS; HEMATOPOIETIC STEM CELL; HUMAN; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; POLYCYSTIC KIDNEY DISEASES; STEM CELL TRANSPLANTATION;

EID: 69449090333     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01144.x     Document Type: Review

References (90)

1. Kiberd B. The chronic kidney disease epidemic: stepping back and looking forward. J. Am. Soc. Nephrol. 2006 17 : 2967 2973.
2. Lysaght M. Maintenance dialysis population dynamics current trends and long-term implications. J. Am. Soc. Nephrol. 2002 13 : S37 40.
3. Little MH. Regrow or repair - potential regenerative therapies for the kidney. J. Amer. Society Nephrol. 2006 17 : 2390 2401.
4. Poulsom R, Forbes SJ, Hodivala-Dilke K et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J. Pathol. 2001 195 : 229 235.
5. Lin F, Igarashi P. Searching for stem/progenitor cells in the adult mouse kidney. J. Am. Soc. Nephrol. 2003 14 : 3290 3292.
6. Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J. Clin. Invest. 2005 115 : 1756 1764.
7. Duffield JS, Bonventre JV. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int. 2005 68 : 1956 1961.
8. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 2007 18 : 2486 2496.
9. Imberti B, Morigi M, Tomasoni S et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J. Am. Soc. Nephrol. 2007 18 : 2921 2928.
10. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal. Physiol. 2005 289 : F31 42.
11. Imasawa T, Nagasawa R, Utsunomiya Y et al. Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int. 1999 56 : 1809 1817.
12. Kunter U, Rong S, Boor P et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 2007 18 : 1754 1764.
13. Hopkins C, Li J, Rae F, Little MH. Stem cell options for kidney disease. J. Pathol. 2009 217 : 265 281.
14. Lazzeri E, Crescioli C, Ronconi E et al. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J. Am. Soc. Nephrol. 2007 18 : 3128 3138.
15. Inowa T, Hishikawa K, Takeuchi T, Kitamura T, Fujita T. Isolation and potential existence of side population cells in adult human kidney. Int. J. Urol. 2008 15 : 272 274.
16. Appel D, Kershaw DB, Smeets B et al. Recruitment of podocytes from glomerular parietal epithelial cells. J. Am. Soc. Nephrol. 2009 20 : 333 343.
17. Ronconi E, Sagrinati C, Angelotti ML et al. Regeneration of glomerular podocytes by human renal progenitors. J. Am. Soc. Nephrol. 2009 20 : 322 332.
18. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008 455 : 627 632.
19. Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J. Am. Soc. Nephrol. 2005 16 : 3527 3534.
20. Steenhard BM, Isom KS, Cazcarro P et al. Integration of embryonic stem cells in metanephric kidney organ culture. J. Am. Soc. Nephrol. 2005 16 : 1623 1631.
21. Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif. 2008 41 (Suppl 1 51 6.
22. Cochrane A, Kett M, Samuel CS et al. Renal structural and functional repair in a mouse model of reversal of ureteric obstruction. J. Amer. Soc. Nephrol. 2005 16 : 3623 3630.
23. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 2007 334 : 115 124.
24. Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells 2006 24 : 3 12.
25. Hishikawa K, Marumo T, Miura S et al. Musculin/MyoR is expressed in kidney side population cells and can regulate their function. J. Cell Biol. 2005 169 : 921 928.
26. Vogetseder A, Picard N, Gaspert A, Walch M, Kaissling B, Le Hir M. Proliferation capacity of the renal proximal tubule involves the bulk of differentiated epithelial cells. Am. J. Physiol. Cell Physiol. 2008 294 : C22 8.
27. Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008 2 : 284 291.
28. Lange C, Togel F, Ittrich H et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005 68 : 1613 1617. (Pubitemid 43169906)
29. Broekema M, Harmsen MC, van Luyn MJ et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J. Am. Soc. Nephrol. 2007 18 : 165 175.
30. Semedo P, Wang PM, Andreucci TH et al. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant. Proc. 2007 39 : 421 423.
31. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal. Physiol. 2007 292 : F1626 35.
32. Hagiwara M, Shen B, Chao L, Chao J. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum. Gene. Ther. 2008 19 : 807 819.
33. Shi H, Patschan D, Dietz GP, Bahr M, Plotkin M, Goligorsky MS. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury. Am. J. Physiol. Renal. Physiol. 2008 294 : F229 35.
34. Togel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 2008 (epub).
35. Gupta S, Verfaillie C, Chmielewski D et al. Isolation and characterization of kidney-derived stem cells. J. Am. Soc. Nephrol. 2006 17 : 3028 3040.
36. Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J. Clin. Invest. 2004 114 : 795 804.
37. Kitamura S, Yamasaki Y, Kinomura M et al. Establishment and characterisation of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J. 2005 19 : 1789 1797.
38. Dekel B, Zangi L, Shezen E et al. Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J. Am. Soc. Nephrol. 2006 17 : 3300 3014.
39. Chen J, Park HC, Addabbo F et al. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int. 2008 (epub).
40. Bussolati B, Bruno S, Grange C et al. Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol. 2005 166 : 545 555.
41. Sagrinati C, Netti GS, Mazzinghi B et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J. Am. Soc. Nephrol. 2006 17 : 2443 2456.
42. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int. J. Mol. Med. 2004 14 : 1035 1041.
43. Herrera MB, Bussolati B, Bruno S et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007 72 : 430 441.
44. Iwasaki M, Adachi Y, Minamino K et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J. Am. Soc. Nephrol. 2005 16 : 658 666.
45. Morigi M, Introna M, Imberti B et al. Human bone marrow-mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008 26 : 2075 2082.
46. Morigi M, Buelli S, Angioletti S et al. In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am. J. Pathol. 2005 166 : 1309 1320.
47. Kinomura M, Kitamura S, Tanabe K et al. Amelioration of cisplatin-induced acute renal injury by renal progenitor-like cells derived from the adult rat kidney. Cell Transplant. 2008 17 : 143 158.
48. Yamashita S, Maeshima A, Nojima Y. Involvement of renal progenitor tubular cells in epithelial-to-mesenchymal transition in fibrotic rat kidneys. J. Am. Soc. Nephrol. 2005 16 : 2044 2051.
49. Roufosse C, Bou-Gharios G, Prodromidi E et al. Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. J. Am. Soc. Nephrol. 2006 17 : 775 782.
50. Fang TC, Alison MR, Cook HT, Jeffery R, Wright NA, Poulsom R. Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J. Am. Soc. Nephrol. 2005 16 : 1723 1732.
51. Fang TC, Otto WR, Rao J et al. Haematopoietic lineage-committed bone marrow cells, but not cloned cultured mesenchymal stem cells, contribute to regeneration of renal tubular epithelium after HgCl(2)-induced acute tubular injury. Cell Prolif. 2008a 41 : 575 591.
52. Fang TC, Otto WR, Jeffery R et al. Exogenous bone marrow cells do not rescue non-irradiated mice from acute renal tubular damage caused by HgCl2, despite establishment of chimaerism and cell proliferation in bone marrow and spleen. Cell Prolif. 2008b 41 : 592 606.
53. Yen TH, Alison MR, Cook HT et al. The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment. Cell Prolif. 2007 40 : 143 156.
54. Guillot PV, Cook HT, Pusey CD et al. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J. Pathol. 2008 214 : 627 636.
55. Ninichuk V, Gross O, Segerer S et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4α3-deficient mice. Kidney Int. 2006 70 : 121 129.
56. Sugimoto H, Mundel TM, Sund M, Xie L, Cosgrove D, Kalluri R. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc. Natl. Acad. Sci. USA 2006 103 : 7321 7326.
57. Prodromidi EI, Poulsom R, Jeffery R et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 2006 24 : 2448 2455.
58. Imasawa T, Nagasawa R, Utsunomiya Y et al. Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int. 1999 56 : 1809 1817.
59. Imasawa T, Utsunomiya Y. Stem cells in renal biology: bone marrow transplantation for the treatment of IgA nephropathy. Exp. Nephrol. 2002 10 : 51 8.
60. Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yanez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol. Blood Marrow Transplant. 2008 14 : 631 640.
61. Kunter U, Rong S, Djuric Z et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J. Am. Soc. Nephrol. 2006 17 : 2202 2212.
62. Wong CY, Cheong SK, Mok PL, Leong CF. Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model. Pathology 2008 40 : 52 7.
63. Li J, Deane JA, Campanale NV, Bertram JF, Ricardo SD. The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 2007 25 : 697 706.
64. Kim SS, Park HJ, Han J et al. Improvement of kidney failure with fetal kidney precursor cell transplantation. Transplantation 2007 83 : 1249 1258.
65. Choi S, Park M, Kim J, Hwang J, Park S, Lee Y. The role of mesenchymal stem cells in the functional improvement of the chronic renal failure. Stem Cells Dev. 2008 (In press).
66. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N. Engl. J. Med. 1996 334 : 1448 1460.
67. Wei Q, Wang MH, Dong Z. Differential gender differences in ischemic and nephrotoxic acute renal failure. Am. J. Nephrol. 2005 25 : 491 499.
68. Issa N, Messer J, Paganini EP. Renal assist device and treatment of sepsis-induced acute kidney injury in intensive care units. Contrib. Nephrol. 2007 156 : 419 427.
69. Yasuda H, Yuen PS, Hu X, Zhou H, Star RA. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney. Int. 2006 69 : 1535 1542.
70. Humes HD, Weitzel WF, Bartlett RH et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 2004 66 : 1578 1588.
71. Gabizon D, Goren E, Shaked U, Averbukh Z, Rosenmann E, Modai D. Induction of chronic renal failure in the mouse: a new model. Nephron. 1985 40 : 349 352.
72. Drewa T, Joachimiak R, Kaznica A, Flisinski M, Brymora A, Manitius J. Bone marrow progenitors from animals with chronic renal failure lack capacity of in vitro proliferation. Transplant. Proc. 2008 40 : 1668 1673.
73. Yokoo T, Fukui A, Ohashi T et al. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J. Am. Soc. Nephrol. 2006 17 : 1026 1034.
74. Anders H, Schlöndorff D. Murine models of renal disease: possibilities and problems in studies using mutant mice. Exp. Nephrol. 2000 8 : 181 193.
75. Inada A, Kanamori H, Arai H et al. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. J. Cell Physiol. 2008 215 : 383 391.
76. Allen TJ, Cooper ME, Lan HY. Use of genetic mouse models in the study of diabetic nephropathy. Curr. Diab. Rep. 2004 4 : 435 440.
77. Gärtner K. Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (c57bl/6j db/db and c57bl/ksj db/db). Diabetologia 1978 15 : 59 63.
78. Cohen MP, Clements RS, Hud E, Cohen JA, Ziyadeh FN. Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. Exp. Nephrol. 1996 4 : 166 171.
79. Lee RH, Seo MJ, Reger RL et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. U S A 2006 103 : 17438 17443.
80. Putaala H, Soininen R, Kilpeläinen P, Wartiovaara J, Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum. Mol. Genet. 2001 10 : 1 8.
81. Miner JH, Sanes JR. Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome. J. Cell Biol. 1996 135 : 1403 1413.
82. Gross O, Borza DB, Anders HJ et al. Stem cell therapy for Alport syndrome: the hope beyond the hype. Nephrol. Dial. Transplant. 2009 24 : 731 734.
83. Kang JS, Wang XP, Miner JH et al. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice. J. Am. Soc. Nephrol. 2006 17 : 1962 1969.
84. Katayama K, Kawano M, Naito I et al. Irradiation prolongs survival of Alport mice. J. Am. Soc. Nephrol. 2008 19 : 1692 1700.
85. Chapman AB. Autosomal dominant polycystic kidney disease: time for a change?. J. Am. Soc. Nephrol. 2007 18 : 1399 1407.
86. Avner ED, Sweeney WE Jr. Renal cystic disease: new insights for the clinician. Pediatr. Clin. North. Am. 2006 53 : 889 909.
87. Thivierge C, Kurbegovic A, Couillard M, Guillaume R, Coté O, Trudel M. Overexpression of PKD1 causes polycystic kidney disease. Mol. Cell Biol. 2006 26 : 1538 1548.
88. Guay-Woodford LM. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am. J. Physiol. Renal. Physiol. 2003 285 : F1034 49.
89. Dorin JR, Farley R, Webb S et al. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene. Ther. 1996 3 : 797 801.
90. Masoumi A, Reed-Gitomer B, Kelleher C, Schrier RW. Potential pharmacological interventions in polycystic kidney disease. Drugs 2007 67 : 2495 2510.